Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

New policies for autonomic nervous system testing

May 26, 2017

[

Independence has developed new policies to communicate our coverage position on autonomic nervous system (ANS) testing for commercial and Medicare Advantage products. ANS testing can be used as a diagnostic tool to evaluate if a patient?s signs and symptoms correlate with autonomic dysfunction and then assist in the clinical decision-making process.

For more information and a complete list of medical necessity criteria for ANS testing, please refer to the following policies, which are currently posted as Notifications and will go into effect August 1, 2017.

  • Commercial: #07.03.23: Autonomic Nervous System Testing
  • Medicare Advantage: #MA07.027: Autonomic Nervous System Testing

To view the Notifications for these policies, visit our Medical Policy Portal and select Accept and Go to Medical Policy Online. Then select either Commercial or Medicare Advantage under Active Notifications.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.